Bryan D’Alessandro – The Power of Plant Medicine/CBD – BlogTalkRadio

  • Broadcast in Health
Sharry Edwards

Featured Host

h:79178
s:11788711
archived

Bryan D’Alessandro is the Co-Founder, CEO of hemp wellness company Eaton Hemp. Offering a line of best-in-class organic CBD products, Bryan’s mission is to empower people to take their health back into their own hands. D’Alessandro’s wellness and spiritual journey began over 15 years ago when diagnosed with a potentially life-threatening auto-immune disease. This caused him to reflect on his well-being and make severe changes that have led to a vegan diet, becoming a certified yoga instructor, and a life of seeking greater truth. A big believer in the power of plant medicine, he found a deep connection with the hemp plant and CBD’s unique way of working with the body’s innate healing abilities.

D’Alessandro wants to share with you how Eaton Hemp Organic Full Spectrum CBD can aid in:

  • Reducing inflammation
  • Recovery
  • Anti-anxiety
  • Sleep support
  • Hemp Hearts high in nutrition

EatonHemp.com

The Core Values of Eaton Hemp

Eaton Hemp Hub ~clarifying information on Hemp and CBD 

Comments

Global Cannabidiol Oil (CBD Oil) Market Research Report: CAGR Status, Industry Growth, Trends, Analysis and Forecasts to 2025 – Chelanpress

Market Study Report LLC Adds New Global Cannabidiol Oil (CBD Oil) Market Report to its research database. The report presents a deep study of the market growth factors and drivers, application potential and much more.

The Cannabidiol Oil (CBD Oil) market report offers significant information regarding this business vertical. As per the document, the market is estimated to record considerable growth as well as amass notable gains during the estimated timeframe.

Request a sample Report of Cannabidiol Oil (CBD Oil) Market at: https://www.marketstudyreport.com/request-a-sample/2439194?

The study elaborates the major trends of Cannabidiol Oil (CBD Oil) market while evaluating the growth opportunities, industry size, volume of sales and revenue predictions. The report also provides a detailed assessment of the various segmentations and their respective impact on the overall market outlook. Moreover, it analyzes the effect of COVID-19 pandemic on the growth rate as well as remuneration generation of the market.

Objectives of the Cannabidiol Oil (CBD Oil) Market Research Report:

  • To provide a detailed analysis of the market structure along with a forecast for the next six years of various segments and sub-segments of the global Cannabidiol Oil (CBD Oil) industry
  • To provide insights into factors affecting market growth
  • To analyze the global Cannabidiol Oil (CBD Oil) industry based on various tools, such as Supply Chain Analysis and Porter’s Five Forces Analysis
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to regions and their respective key countries
  • To provide country-level analysis of the market with respect to the current market size and future prospects
  • To provide country-level analysis of the market for segments by type and region
  • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Cannabidiol Oil (CBD Oil) industry

Ask for Discount on Cannabidiol Oil (CBD Oil) Market Report at: https://www.marketstudyreport.com/check-for-discount/2439194?

Other data specified in the Cannabidiol Oil (CBD Oil) market report:

  • The study comprises of a granular analysis of the competitive arena of the Cannabidiol Oil (CBD Oil) market. The major companies operating the market are Kazmira, Cannavest, Green Road, CW Hemp/CW Botanicals, HempLife Today, Freedom Leaf, ENDOCA, Folium Biosciences, Medical Marijuana, Pharmahemp, Canopy Growth Corporation, Whistler, CBD American Shaman, Absolute Terps, Aphria, K.I.N.D. Concentrates, NuLeaf Naturals, The Lab, Emblem Cannabis Oils and Select Oil.
  • Information regarding products manufactured by each firm and their application range is enumerated.
  • Other insights related to the revenues generated and market position of all the product types are offered in the study.
  • The report unveils data regarding the pricing models as well as profitability graph of every company mentioned.
  • Based on the product landscape, the report divides the Cannabidiol Oil (CBD Oil) market into Hemp-derived Type and Marijuana-derived Type.
  • Significant information concerning revenues acquired, market share and sales patterns are analyzed and provided in the study.
  • The application scope of the Cannabidiol Oil (CBD Oil) market comprises of Pharmaceuticals Industry, Food Industry, Cosmetics Industry and Other.
  • The document provides information such as revenues accumulated and sales volume of each application type over the study period.
  • It also emphasizes on the business-centric attributes including market concentration rate and commercialization matrix.
  • Various marketing strategies adopted by leading companies are also underlined in the report.

As per the regional scope of Cannabidiol Oil (CBD Oil) market:

  • The document delivers crucial insights pertaining to the regional terrain of the Cannabidiol Oil (CBD Oil) market and categorizes the same into North America, Europe, Asia-Pacific, South America, Middle East and Africa.
  • Data regarding the returns generated alongside market share that each region holds is highlighted.
  • Predicted growth rate and revenue forecasts of every region mentioned is also enlisted.

For More Details On this Report: https://www.marketstudyreport.com/reports/global-cannabidiol-oil-cbd-oil-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Related Reports:

1. Global Phenylketonuria (PKU) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
The Phenylketonuria (PKU) Market Report offer the complete scenario of the industry and valuation of upcoming Trends for future market. It also gives the analytic of enduring growth factor, trends and statistic of Phenylketonuria (PKU) Market industry. The Phenylketonuria (PKU) Market has been outlined by overall information and analysis.
Read More: https://www.marketstudyreport.com/reports/global-phenylketonuria-pku-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

2. Global Construction Chemicals Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Construction Chemicals Market report starts from illustration of Industry Chain structure, and portrays industry condition, at that point investigations advertise size and figure of Construction Chemicals by item, district and application, likewise, this report presents showcase rivalry circumstance among the merchant’s profile, plus, advertise value examination and esteem chain highlights are canvassed in this report.
Read More: https://www.marketstudyreport.com/reports/global-construction-chemicals-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Contact Us:
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: [email protected]

A Massive Swing in Cannabis Sector Sentiment – New Cannabis Ventures

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news.

Friends,

For the past couple of years, we and others pointed to better fundamentals and valuations for large American MSOs than for Canadian LPs, and the recent price performance illustrates just how quickly sentiment has shifted. In 2020, each of the four largest American MSOs by market cap has outperformed the largest Canadian LPs:

The separation is most evident by looking at the action over the past three months, with the four MSOs up 83-106% while the very best Canadian LP is up 23%:

Driving the separation, in our view, is a better appreciation of the financials of American operators relative to the Canadian LPs, optimism surrounding the expansion of state-legal programs and potential improvements in federal policy. Over the past few months, the Canadian LPs have reported lower revenue levels and growth, larger operating losses and big write-downs of inventory and even production facilities. The largest MSOs are on a tear, with likely three of them to report Q2 revenue in excess of $100 million. The table below, converted to American dollars, illustrates this point:

The 9 companies are sorted by the most recent quarterly cannabis revenue, with 4 of the top 5 spots belonging to MSOs, all of which more than doubled cannabis revenue in the most recent quarter. Not all of this growth was organic. The adjusted operating income, which does include impairments, indicates that all five Canadian LPs had lower income than the MSOs, two of which were profitable. We include market caps, which are based on fully-diluted in-the-money shares, and, with the exception of Canopy Growth, all of the MSOs have higher market caps now than the Canadian LPs.

We didn’t include net debt positions, but doing so would not change the conclusion here that investors are now valuing the largest MSOs above the LPs. Since Canopy Growth is the one exception, we note that the company does have net cash, but it also has been seeing the largest cash outflows. Cronos has substantial net cash, while Aphria has a small amount. Aurora and Tilray have net debt. Each of the MSOs has net debt, though it’s not particularly large relative to the market cap.

On Monday, Canopy Growth will be reporting its fiscal Q1, and the company is expected to have seen revenue up about 4% from a year ago and to see a rather large operating loss. It’s not clear to us why its market cap exceeds the combined total of its four peers, but clearly investors value the Constellation Brands strategic partnership. The more interesting question that investors will surely debate ahead is what is the right relationship between the valuations between MSOs and LPs. Clearly, revenue level, revenue growth and profitability favor higher valuations for the MSOs, and, with the exception of Canopy Growth, that is the case.

We remind our readers that cannabis remains illegal federally in the U.S., and this is something that valuations need to reflect. Taking that idea a bit further, it’s important to remember that American operators are subject to onerous taxation (280E). Further, federal illegality prevents American operators from pursuing some global opportunities. So, in our view, investors need to understand that there are some extra risks and costs that must be factored in when evaluating MSOs relative to Canadian LPs.

Looking ahead, we think the fundamentals will remain quite strong in the U.S. and improve in Canada, where LPs have been rationalizing their production assets and inventories as they adjust to the reality of a market that is less robust than they had anticipated. The roll out of new types of products and the expansion in the number of retail stores could help improve the fundamentals as well. Investors have clearly shifted their interest to the MSOs, but if the Canadian LPs are able to resume growth and continue to make progress in their cost structure, investors could be rewarded over time.


Helping Cannabis Investors Navigate a New Sector Since 2013

Alan Brochstein’s 420 Investor is the only due diligence platform trusted by cannabis investors for over 6 years. The go-to premium service for investors to learn, explore, and profit from publicly-traded cannabis stocks. The primary goal of 420 Investor is to provide professional, real-time, objective information about the top cannabis companies in the market in order to help investors Capitalize on Cannabis™.


New Cannabis Ventures publishes curated articles as well as exclusive news. Here is some of the most interesting business content from this week:


To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter. Share and discover industry news with like-minded people on the largest cannabis investor and entrepreneur group on LinkedIn.

Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013. Gain immediate access to real-time and in-depth information and market intelligence about the publicly traded cannabis sector, including daily videos, weekly chats, model portfolios, a community forum and much more.

Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames. In addition to the comprehensive Global Cannabis Stock Index, we offer a family of indices to track Canadian licensed producers as well as the American Cannabis Operator Index.

View the Public Cannabis Company Revenue & Income Tracker, which ranks the top revenue producing cannabis stocks that generate industry sales of more than US$10M per quarter.

Stay on top of some of the most important communications from public companies by viewing upcoming cannabis investor earnings conference calls.

Discover upcoming new listings with the curated Cannabis Stock IPOs and New Issues Tracker.

Sincerely,

Alan & Joel

Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter


Cannabis before sex can help men access a deeper level of intimacy, study finds – Business Insider South Africa

Crystal Cox/Business Insider

  • For a recent study, researchers interviewed 41 non-straight men about their cannabis use during sex and found that many reported the substance improved their experiences.
  • Some said cannabis helped them physically, like lasting longer in bed, enjoying different sex acts, or having more intense orgasms.
  • Others said cannabis helped lower their inhibitions, feel less shame, and be more intimate with their partners.
  • The researchers said cannabis could be a helpful sexual tool, especially in place of more dangerous and addictive drugs like meth.
  • For more stories go to www.BusinessInsider.co.za.

People who experience anxiety and shame during sex could find benefits in using cannabis in the bedroom, according to a new study.

The small study, which was published May 28 in the journal Culture, Health & Sexuality, involved interviews with 41 men who were between 15 and 30 years old, and who didn’t identify as straight. Three of the men were transgender, 36 were cisgender, and the remainder didn’t identify with a particular gender.

The researchers interviewed these men for up to two hours about their experiences using cannabis during sex within the past year. They found that the majority of participants said that using cannabis before sex increased sexual pleasure and lowered their inhibitions, and that the substance also helped them to feel less anxious and therefore be more intimate during sex.

According to the researchers, their findings suggest cannabis could be a helpful tool for men of sexual minorities and struggle with sex stigma-related anxiety.

„In other words, the sexualised use of cannabis can help sexual and gender minority men overcome feelings of anxiety and shame resulting from internalised homophobia, biphobia and/or transphobia, so that they can more fully enjoy the sex they want,” the researchers wrote for The Conversation.

Cannabis helped some of the men enjoy anal sex more

Others said cannabis helped them to last longer in bed, or that it made typically pleasurable sensations even more pleasurable.

Crystal Cox/Business Insider

In interviewing the 41 men, the researchers found that many liked using cannabis during sex because it increased feelings of physical pleasure and made pleasurable sexual experiences that had previously been unenjoyable.

„I’ve been having anal sex for, like, probably a decade, but until very, very, very recently while having an edible [i.e. ingesting cannabis], I’ve never actually liked it… It’s never been better than a six out of ten,” one study participant told the researchers.

„I’m actually enjoying this for like the first time, solidly, like a nine out of ten [after taking the edible]! And then the next time I had sex without an edible, I was enjoying it as an eight out of ten. I’m like, ‚Huh?!’ So it changed something in me.”

Others said cannabis helped them to last longer in bed, or that it made typically pleasurable sensations even more pleasurable.

„I remember when I was in high school and I would have a classic routine,” another study participant told the researchers. „I would get high, I would jerk off. The best orgasms that I’ve ever had was while being high.”

Others said cannabis allowed them to feel more emotionally intimate with their sex partners

The men in the study said using cannabis also affected their emotions about sex.

For gay, bisexual, and transgender men, sexual stigma can prevent them from letting their guards down during sex, but many said cannabis helped lower their inhibitions and become more intimate with their partners.

One study participant, for example, said he grew up in a conservative town and didn’t realize until he went to college in a more liberal area that he was gay.

„And I think that I carry a lot of guilt and shame about that. That is quite unfortunate,” he said.

When a researcher asked him if cannabis helped him to let go of those feelings of guilt and shame during sex, he said it did.

„And then [after sex] as well. Like, that’s when I would feel ashamed normally. But if you’re under some sort of substance then you, you know, even afterwards you feel okay,” he said.

Other respondents said using cannabis during sex helped them to be less judgmental towards themselves and other non-straight people, and that it also quelled anxiety around STI transmission.

The small nature of the study, and its focus on non-straight men from one particular region, mean that the results may not be applicable to the entire population. Nonetheless, the researchers believe their findings offer insights into how cannabis can improve people’s sex lives.

Cannabis could be a therapeutic sex tool

Crystal Cox/Business Insider

The researchers concluded the cannabis could be a tool for helping people, especially marginalized groups, overcome sex stigma and improve their sex lives.

They said that cannabis’ low risk for addiction and virtually non-existent overdose risk make it a better alternative to other drugs, like meth, that non-straight people may use to lower their inhibitions during sex.

The researchers also said that cannabis could be useful during the pandemic, since people are isolating from others and may be more inclined to try virtual sex.

„Cannabis may prove useful in these times to help cultivate feelings of intimacy and connectedness in virtual settings, and thus facilitate online hookups,” the researchers wrote for The Conversation.

Receive a daily update on your cellphone with all our latest news: click here.

Get the best of our site emailed to you daily: click here.

Also from Business Insider South Africa:

Two remanded for eight days after over 2.5kg cannabis found – Cyprus Mail

An eight-day-remand order was issued against two men by the Nicosia District Court on Sunday after they were arrested with 2,730g of cannabis.

At around 1pm on Saturday members of the anti drugs squad stopped for checking cars that were being driven by a 25-year-old and a 24-year-old.

In the car of the former they also found six packages containing dried cannabis weighing 2,730g in addition to €310.

Further items were taken as evidence from the two cars while both were arrested with a court warrant.

‚Not marijuana’: U.S. hemp farmers battle tough market and thieves – CTV News

STANLEY, VA. — When she planted hemp to make extra money for her family farm, Susan Corbett did not imagine thieves would find their way to her rural plot in Virginia to steal the plants.

And yet they did — one of many bends in the wild and sometimes bumpy ride hemp farmers have had since the crop was legalized in the United States in 2018.

Two security cameras now watch over a portion of Corbett’s crop, which looks and smells like marijuana but contains very little tetrahydrocannabinol (THC), which is what gets users high.

Also warning would-be pilferers is a sign whose bold black letters read: „This is not marijuana.”

„I don’t know what they were doing with it,” Corbett said of her looted plants. „There’s no THC in it.”

Hemp is in demand for its seeds, fiber and oil containing the relaxing cannabinoid CBD — but it’s also the same plant as marijuana, which remains illegal federally and under varying restrictions in most American states.

Besides an oversaturated market and laborious cultivation process, hemp farmers hoping to profit from the newly legitimized plant say they have had to navigate suspicious police, a legal mandate to burn crops that exceed THC limits and the problem of theft.

„Everybody plants it and goes ‚This is wonderful,'” said Corbett. „I said ‚Just wait.'”

IT’S NOT EASY

One of the world’s oldest cultivated plants, the U.S. banned hemp during the 20th century before allowing its growing for research starting in 2014, then legalizing it nationwide four years later.

Forty-six states have since passed laws regulating its cultivation, with hemp licenses in 34 states growing 455 per cent last year over 2018, according to Vote Hemp, an advocacy group.

CBD, whether sold as a supplement or mixed into food or drinks, has also grown popular, and financial services firm Canaccord Genuity predicts CBD sales will jump 45 percent to YS$18 billion by 2024.

Those who grow hemp describe a demanding crop that must be harvested by hand, maintained with a rigorous spraying schedule to keep away pests then dried out before it can be sold.

With so much of the plant hitting the market, and a shortage of processors, many farmers are seeing buyers back out of agreements.

„When we go to the CBD market, it’s ‚We’ll pay you when we get paid,’ which puts us in a problem with our creditors,” said David Turner of DC Hemp, who farms in rural Dinwiddie county, Virginia.

Another peculiarity is the presence of THC in the plant. Farmers must constantly test hemp to ensure the level doesn’t get too high, otherwise they have to burn it.

„If I get the wrong situation where I have a crop out there, I’m a drug lord,” Turner said.

Local media has reported cases of police around the United States seizing hemp shipments on suspicion of being marijuana, so growers have started carrying around a pile of documentation when transporting their harvest.

WHO STEALS HEMP?

And then there are the thieves.

The brigands traipsed into Turner’s fields and yanked plants out of the ground repeatedly when he was growing it last year, while at Corbett’s farm they chopped off the tops of the plants where the buds grow.

Was it to smoke the plant thinking it’s marijuana? Or sell it to unsuspecting buyers? Turner’s not sure, but said local police arrested multiple suspects for the thefts.

Farmers say their real challenge is getting their oil sold. Turner and Corbett both are sitting on gallons of CBD oil, waiting for someone to buy it.

„There definitely was a bit of an oversaturation of the market last year, and in conjunction with that market prices have dropped significantly,” said Erica Stark, executive director of the National Hemp Association.

„It’s still profitable if you can find a buyer, but it’s a big if,” she said, adding that the market situation will improve once processing capacity for hemp fiber grows, and the government passes regulations on CBD’s use as a supplement.

Turner has decided to sit out the 2020 planting season, and Vote Hemp estimates the actual harvest in 2019 was much lower than what farmers were licensed for due to crop failure and non-compliant plants.

„I haven’t gotten rich doing it,” concedes Corbett, who also rents out land to cattle ranchers and hosts guests at her riverside acreage in the town of Stanley.

„I believe in CBD and so, if I do OK this year, I’ll probably commit to five more years.”

3 Most Popular Marijuana Stocks on Robinhood: Are They Buys? – The Motley Fool

You might not be surprised one bit that many Robinhood investors like pot stocks. After all, the trading platform especially appeals to millennials. And millennials support marijuana legalization in higher numbers than any other generation. 

But which pot stocks do Robinhood investors like the most? Here are the three most popular marijuana stocks on the no-commission trading platform — and whether or not they’re smart picks to buy right now. 

Three cannabis leaves

Image source: Getty Images.

1. Aurora Cannabis

Aurora Cannabis (NYSE:ACB) ranked as Robinhood investors’ favorite stock of all in December 2019. It’s now 10 spots lower but still leads all other cannabis stocks on the list of the 100 most popular stocks on the platform.

Keep in mind that Aurora shares have plunged close to 60% so far this year. So why do Robinhood investors still like the stock so much? I think one factor is name recognition. The company has been in the news quite a bit over the last couple of years.

But there are also more substantive reasons for Aurora’s popularity. The cannabis producer is a leader in the Canadian adult-use recreational marijuana and medical cannabis markets as well as in Germany’s medical cannabis market. Aurora’s production costs are low relative to most of the industry while its production capacity is high. After the stock’s huge drop, the company’s market cap is also well below most of its top rivals.

2. Canopy Growth

Canopy Growth (NYSE:CGC) comes in second behind Aurora in popularity among Robinhood investors when it comes to marijuana stocks. That reflects some positive momentum for Canopy: In December, it was in third place.

Perhaps one reason why Canopy is viewed more favorably is its CEO, David Klein. The former Constellation Brands CFO took the helm at Canopy in January. Although it’s been a bumpy ride, Klein has taken firm steps to reduce the company’s spending and get Canopy on a path to profitability.

It could have also impressed Robinhood investors that Constellation upped its stake in Canopy Growth in May. This move reaffirmed the adult-beverage giant’s commitment to the long-term prospects for the cannabis industry and to Canopy’s role as a leader.

3. Cronos Group

Cronos Group (NASDAQ:CRON) slipped a spot from late last year to take the No. 3 position among the most popular pot stocks on Robinhood. It might not be a coincidence that Cronos also is lagging slightly behind Canopy in year-to-date stock performance.

The company hasn’t been in the spotlight all that much in recent months. So how is Cronos hanging onto its status near the top with Robinhood investors? One possibility is that Cronos has a solid U.S. presence thanks to its acquisition of Redwood last year. The deal brought the Lord Jones line of CBD products into Cronos’ lineup.

Cronos also could stand out because of its partnership with Ginkgo Bioworks to develop cannabinoids using fermentation processes. In addition, Robinhood investors might have liked the company’s moves to enter Israel’s medical cannabis market.

Are they buys?

My Motley Fool colleague Sean Williams listed Aurora and Cronos in his list of pot stocks to avoid like the plague in August. I think avoiding the plague would take a much higher priority over staying away from the two Canadian marijuana stocks, but Sean’s general sentiment is on point.

The problem for all three of the most popular pot stocks on Robinhood is that they continue to lose money. This is a more serious issue for Aurora, though, because it doesn’t have deep-pocketed partners like Canopy has with Constellation and Cronos has with Altria Group.

I’m concerned about Aurora’s massive debt load. I’m not convinced that the company will be able to achieve profitability as quickly as it’s said it would. To me, Aurora has too many hurdles to jump to make it a compelling pick.

As for Cronos, my take on the stock isn’t nearly as pessimistic as Sean’s is. However, I’d prefer to see the company make a lot more progress toward profitability.

That leaves Canopy Growth. I think that David Klein has taken smart steps so far and will continue to steer Canopy in the right direction. My hunch is that we’ll see changes to U.S. marijuana laws within the next year or two that will clear the way for Canopy to finalize its acquisition of Acreage Holdings and jump into the U.S. marijuana market.

To be sure, Canopy isn’t my favorite cannabis stock. However, I still think it’s a pretty good pick for investors with the patience to wait a while.

The Cannabis Industry Needs Hard Data on Medical Marijuana. This Study Could Provide It – The Motley Fool

Despite the growing popularity of cannabis, there’s limited information about what the substance can and cannot do. And with marijuana classified as a Schedule 1 substance in the U.S., it’s nearly impossible for researchers to conduct studies on it. In Canada, however, pot’s legal for both medical and recreational use. Researchers there are hopeful that a new study could help answer some of the uncertainties surrounding cannabis and its effectiveness in treating various ailments. 

There’s lots of anecdotal evidence of cannabis helping alleviate various ailments. The Food and Drug Administration (FDA)’s even approved a cannabis-based drug made by GW Pharmaceuticals (NASDAQ:GWPH): Epidiolex. It’s the only FDA-approved drug that’s derived from cannabis and it can treats children with two rare forms of seizures — Dravet syndrome and Lennox-Gastaut syndrome. And the FDA recently approved it for a new indication: treating seizures due to tuberous sclerosis complex. Trulieve Cannabis (OTC:TCNN.F) is another top medical marijuana company and it has benefited from tremendous growth in its home state of Florida. More than 380,000 patients there hold marijuana cards, which is up 28% since the beginning of the year. But despite the demand for medical marijuana, there are still many people who doubt its effectiveness, and that’s why more research and studies are necessary.

An effort to achieve real-world results

The University Health Network (UHN) in Canada is embarking on a six-month study that aims to put some solid data behind claims that cannabis can help patients. The Medical Cannabis Real-World Evidence Study is seeking to enroll at least 2,000 people who have been prescribed medical marijuana for certain conditions including chronic pain, sleep, anxiety, and depression. The study will utilize a portal run by Canadian pharmacy retailer Shoppers Drug Mart that contains accurate and reliable information about the medical cannabis products it sells including dried flower, oils, extracts, edibles, and topical preparations. Patients will select cannabis products from the platform and then report on the product’s effectiveness in treating their symptoms.

Cannabis oil vial with leaf and drawing of cannabis molecule

Image source: Getty Images. 

One of the most important aspects of this study is that patients can have confidence in the accuracy of the cannabidiol (CBD) and tetrahydrocannabinol (THC) levels in every product. Through the use of blockchain and seed-to-sale tracking technology, Shoppers is able to obtain detailed information and chemistry related to a specific product. Knowing the specific strain that’s in a product and its effects on an individual with a particular illness can help to specifically identify what works and what doesn’t under varying circumstances.

However, one of the important limitations of this study is that there isn’t a control group. It’s also dependent on the information that patients report regarding the effectiveness of a particular product. As a result, the data that’s collected can be very subjective and won’t contain the conclusive data that a true scientific study would otherwise provide. In effect, it’s more of a database of patient responses and assessments of various products.  

Why the study is important

For medical marijuana companies like GW and Trulieve, positive results from this study, even though they may only be anecdotal, can help drive demand for their products if companies know which types of products are likely to be effective in treating patients with certain conditions. And if the study helps convince the FDA that cannabis may be safer than the agency thinks it is, that would be a big step forward for the cannabis industry.

The FDA, despite permitting Epidiolex for use, still has doubts about CBD, the compound in cannabis that’s often associated with its health benefits. It issued a warning in November 2019 stating there were many concerns surrounding the safety of CBD.

Although there isn’t a control group in this study to gauge the safety of cannabis, if the patient’s responses from the study are overwhelmingly positive and they report no adverse side effects from using the products, it could at the very least make a case that certain products and strains are safe. The study likely won’t change the FDA’s mind but it could go a long way in encouraging more patients to try cannabis, especially those who may be on the fence. And that, in turn, could help marijuana companies like GW and Trulieve continue to grow their sales.

In 2019, GW reported sales of $311 million in the first full year that Epidiolex was on available, up from just $13 million in the previous year. Trulieve’s revenue last year topped $253 million and grew by 145% despite focusing on just one state. 

What does this mean for investors?

The study is still currently accepting patients and doesn’t have a set start date. It could be well into next year before the study’s complete and researchers are able to analyze and process the findings. It’s something for investors to keep an eye out for as positive results from the study, regardless of whether they sway the opinion of the FDA or health officials. 

For now, it’s still the status quo for investors of GW and Trulieve. Both pot stocks are continuing to perform well and are generating strong sales numbers and remain great buys. Year to date, the stocks are both in positive territory and are outperforming the Horizons Marijuana Life Sciences ETF (OTC:HMLS.F) by wide margins.

GWPH Chart

GWPH data by YCharts

As certain cannabis companies continue to make headway in their total addressable market, pot stocks will probably rise in step with growing sales. And if U.S. federal legalization ever comes to pass, most marijuana stocks will shoot up in a hurry.

ECigarette and Vaporizer Market to Watch: Spotlight on Imperial Tobacco, Reynolds American, Japan Tobacco, Altria, VMR Product, Njoy – Levee Report

ECigarette and Vaporizer Market Research Study  The exploration study consisted of both primary and secondary analysis techniques deriving market data. Government and public solicitation of ideas to reduce the effects of the COVID-19 pandemic by private businesses around the world is called market forces. The objective is to obtain premium insights, quality data statistics, and information on aspects such as market scope, market size, share, and segments like service and product Types, Application / End-Use Sector, SWOT Analysis, and various geography evolving. In the regular version of this study, some of the profiled players are Imperial Tobacco, Reynolds American, Japan Tobacco, Altria, VMR Product, Njoy, 21st Century, Vaporcorp, Truvape, FirstUnion, Hangsen, Buddy Group, Kimree, Innokin, SHENZHEN SMOORE, SMOK.

REQUEST to GET FREE Sample PDF of ECigarette and Vaporizer Market Report NOW! @https://www.amplemarketreports.com/sample-request/covid-19-outbreak-impact-on-global-e-cigarette-and-vaporizer-market-1862707.html

The analysis of ECigarette and Vaporizer  Business integrates useful differentiation data for each of the market segments. These segments are further analyzed on various fronts including historical results, contributions to market size, percent market share, projected growth rate, and many more.

Segmentation or breakdown of key businesses covered in ECigarette and Vaporizer Market Study is by Type [No screen, Containing screen], by Application [, the E-Cigarette and Vaporizer market is segmented into, Online Sales, Offline Sales, Regional and Country-level Analysis, The E-Cigarette and Vaporizer market is analysed and market size information is provided by regions (countries)., The key regions covered in the E-Cigarette and Vaporizer market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc., The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026., Competitive Landscape and E-Cigarette and Vaporizer Market Share Analysis, E-Cigarette and Vaporizer market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of E-Cigarette and Vaporizer by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (] and by Region [North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E].

Business Strategies

The key market in ECigarette and Vaporizer strategies which include product launches, alliances, mergers and acquisitions, and so on discussed in this study. In accordance with undisputed market dynamics, the importance of strategic analysis has been rigorously examined. Market type 1 is expected to dominate the overall market over the forecast period until 2026.

What primary data figures are included in the ECigarette and Vaporizer market report?

  •   Market size (Last few years, current and expected)
  •   Market share analysis as per different companies)
  •   Market Contributions (Size, Share as per regional boundaries)
  •   Market (Demand forecast)
  •   Price Analysis Before and After COVID Situation 

Due to COVID-19, think back to Unleash Growth Pattern; Know More @ 

https://www.amplemarketreports.com/report/covid-19-outbreak-impact-on-global-e-cigarette-and-vaporizer-market-1862707.html

What are the essential aspects of ECigarette and Vaporizer  Market Study?

  •   Industry Value Chain
  •   Key Economic Indicators
  •   Consumption Data
  •   Market Size Expansion

Who will gain most from this ECigarette and Vaporizer Market Report?

  •   Market Investigators
  •   Teams, departments, and companies
  •   Vendors, Buyers, Suppliers
  •   Competitive organizations
  •   Individual professionals
  •   Others

Will you have any questions about this report? Please contact us on: https://www.amplemarketreports.com/buy-report.html?report=1862707&format=1

ECigarette and Vaporizer Market – Geographical Segment

  •   North America (Canada, United States & Mexico)
  •   South America (Argentina, Brazil, Peru, Colombia, Etc.)
  •   Europe (Germany, the United Kingdom, Belgium, Netherlands, France, Russia & Italy, Others)
  •   Asia-Pacific (Japan, South Korea, China, India & Southeast Asia)
  •   Middle East & Africa (United Arab Emirates, Egypt, Saudi Arabia, Nigeria & South Africa)

The ECigarette and Vaporizer Market – Report Allows You to:

  •   Formulate Significant Competitor Information, Analysis, and Insights to Improve R&D Strategies of ECigarette and Vaporizer Market
  •   Plan Mergers and Acquisitions Effectively by Identifying Major Players, CAGR, SWOT Analysis with The Most Promising Pipeline of ECigarette and Vaporizer Market
  •   Identify Emerging Players of ECigarette and Vaporizer Market with Potentially Strong Product Portfolio and Create Effective Counter Strategies to Gain Competitive Advantage
  •   Identify and Understand Important and Diverse Types of ECigarette and Vaporizer Market Under Development
  •   Develop ECigarette and Vaporizer Market Entry and Market Expansion Strategies
  •   In-Depth Analysis of the Product’s Current Stage of Development, Territory and Estimated Launch Date of ECigarette and Vaporizer Market

Buy full report now   @ https://www.amplemarketreports.com/buy-report.html?report=1862707&format=1

 **Please let us know if you have any special requirements and we will provide an ad-hoc personalized report according to your requirement to meet your objectives

About Author

Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to deliver reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.

Contact Address: 

William James 

Media & Marketing Manager 

Address: 3680 Wilshire Blvd, Ste P04 – 1387 Los Angeles, CA 90010

Call: +1 (530) 868 6979 

Email: [email protected] 

https://www.amplemarketreports.com